King, J., Althouse, S. K., Zang, Y., Salous, T., Hanna, N. H., Einhorn, L. H., Adra, N. (2026). A phase II trial of cabozantinib in relapsed refractory germ-cell tumors (GCT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.587